Variant report
| Variant | nsv600664 |
|---|---|
| Chromosome Location | chr5:179221789-179228623 |
| allele | n/a |
| Outlinks | Ensembl   UCSC |
- TF binding region (count:768)
- CpG islands (count:1222)
- Chromatin interactive region (count:26)
- LncRNA region (count:0)
- Mature miRNA region (count: 2)
- miRNA target sites (count:0)
| No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
|---|---|---|---|---|---|---|
| 1 | ATF2 | chr5:179222984-179223659 | GM12878 | blood: | n/a | n/a |
| 2 | ATF2 | chr5:179223385-179223971 | H1-hESC | embryonic stem cell: | n/a | n/a |
| 3 | ATF2 | chr5:179223566-179223919 | H1-hESC | embryonic stem cell: | n/a | n/a |
| 4 | ATF3 | chr5:179223092-179223504 | A549 | lung: | n/a | n/a |
| 5 | BACH1 | chr5:179222270-179223747 | H1-hESC | embryonic stem cell: | n/a | n/a |
| 6 | BCL3 | chr5:179228161-179228577 | GM12878 | blood: | n/a | n/a |
| 7 | BCL3 | chr5:179222480-179223805 | GM12878 | blood: | n/a | chr5:179223789-179223798 |
| 8 | BCL3 | chr5:179223054-179224057 | A549 | lung: | n/a | chr5:179223789-179223798 chr5:179223959-179223972 |
| 9 | BCL3 | chr5:179223068-179223847 | A549 | lung: | n/a | chr5:179223789-179223798 |
| 10 | BCL3 | chr5:179223079-179223543 | GM12878 | blood: | n/a | n/a |
| 11 | BCLAF1 | chr5:179223062-179223634 | GM12878 | blood: | n/a | n/a |
| 12 | BCLAF1 | chr5:179223083-179223663 | GM12878 | blood: | n/a | n/a |
| 13 | BHLHE40 | chr5:179223073-179223566 | GM12878 | blood: | n/a | n/a |
| 14 | BHLHE40 | chr5:179223155-179223492 | HepG2 | liver: | n/a | n/a |
| 15 | BRCA1 | chr5:179223685-179223709 | HepG2 | liver: | n/a | n/a |
| 16 | BRCA1 | chr5:179223323-179223490 | GM12878 | blood: | n/a | n/a |
| 17 | CCNT2 | chr5:179223273-179223720 | K562 | blood: | n/a | n/a |
| 18 | CCNT2 | chr5:179222707-179222891 | K562 | blood: | n/a | n/a |
| 19 | CEBPB | chr5:179223187-179223281 | H1-hESC | embryonic stem cell: | n/a | n/a |
| 20 | CEBPB | chr5:179223236-179223333 | Hela-S3 | cervix: | n/a | n/a |
| 21 | CEBPD | chr5:179223154-179223753 | HepG2 | liver: | n/a | n/a |
| 22 | CHD1 | chr5:179223194-179223534 | H1-hESC | embryonic stem cell: | n/a | n/a |
| 23 | CHD1 | chr5:179223149-179223623 | GM12878 | blood: | n/a | n/a |
| 24 | CHD2 | chr5:179222316-179222670 | HepG2 | liver: | n/a | n/a |
| 25 | CHD2 | chr5:179222299-179222471 | H1-hESC | embryonic stem cell: | n/a | n/a |
| 26 | CHD2 | chr5:179223188-179223571 | Hela-S3 | cervix: | n/a | n/a |
| 27 | CHD2 | chr5:179223133-179223502 | HepG2 | liver: | n/a | n/a |
| 28 | CHD2 | chr5:179222334-179222507 | Hela-S3 | cervix: | n/a | n/a |
| 29 | CHD2 | chr5:179223653-179223908 | H1-hESC | embryonic stem cell: | n/a | n/a |
| 30 | CHD2 | chr5:179222364-179222514 | GM12878 | blood: | n/a | n/a |
| 31 | CHD2 | chr5:179223137-179223426 | H1-hESC | embryonic stem cell: | n/a | n/a |
| 32 | CHD2 | chr5:179223113-179223524 | GM12878 | blood: | n/a | n/a |
| 33 | CREB1 | chr5:179222843-179223534 | A549 | lung: | n/a | n/a |
| 34 | CREB1 | chr5:179222109-179223993 | HepG2 | liver: | n/a | n/a |
| 35 | CTBP2 | chr5:179223061-179224132 | H1-hESC | embryonic stem cell: | n/a | n/a |
| 36 | CTCF | chr5:179222953-179223515 | MCF-7 | breast: | n/a | n/a |
| 37 | CTCF | chr5:179223107-179223442 | MCF-7 | breast: | n/a | n/a |
| 38 | CTCF | chr5:179223160-179223310 | GM12872 | blood: | n/a | n/a |
| 39 | CTCF | chr5:179222860-179223010 | HCFaa | heart: | n/a | n/a |
| 40 | CTCF | chr5:179223200-179223350 | GM12868 | blood: | n/a | n/a |
| 41 | CTCF | chr5:179223560-179223710 | AG09309 | skin: | n/a | n/a |
| 42 | CTCF | chr5:179222760-179222910 | GM12868 | blood: | n/a | n/a |
| 43 | CTCF | chr5:179222800-179222950 | AG04449 | skin: | n/a | n/a |
| 44 | CTCF | chr5:179223099-179223480 | Spleen_OC | spleen: | n/a | n/a |
| 45 | CTCF | chr5:179223660-179223810 | GM12864 | blood: | n/a | n/a |
| 46 | CTCF | chr5:179223160-179223310 | AG09309 | skin: | n/a | n/a |
| 47 | CTCF | chr5:179223180-179223330 | GM12869 | blood: | n/a | n/a |
| 48 | CTCF | chr5:179223200-179223350 | NHEK | skin: | n/a | n/a |
| 49 | CTCF | chr5:179222020-179222170 | GM12875 | blood: | n/a | n/a |
| 50 | CTCF | chr5:179223520-179223670 | HCFaa | heart: | n/a | n/a |
| No. | Chromosome Location | Cell Line | Cell type | Cell Stage |
|---|---|---|---|---|
| 1 | chr5:179226172-179226222 | GM12892 | blood: | n/a |
| 2 | chr5:179225039-179225089 | T-47D | breast: | n/a |
| 3 | chr5:179226172-179226222 | GM12892 | blood: | n/a |
| 4 | chr5:179225039-179225089 | T-47D | breast: | n/a |
| 5 | chr5:179228489-179228539 | HAEpiC | amniotic membrane: | n/a |
| 6 | chr5:179226186-179226236 | HCM | heart: | n/a |
| 7 | chr5:179225504-179225554 | BJ | skin: | n/a |
| 8 | chr5:179225515-179225565 | HUVEC | blood vessel: | n/a |
| 9 | chr5:179225479-179225529 | A549 | lung: | n/a |
| 10 | chr5:179223454-179223504 | RPTEC | kidney: | n/a |
| 11 | chr5:179224563-179224613 | AoSMC | blood vessel: | n/a |
| 12 | chr5:179228489-179228539 | MCF10A-Er-Src | breast: | n/a |
| 13 | chr5:179223454-179223504 | HPAEpiC | pulmonary alveolar: | n/a |
| 14 | chr5:179223116-179223166 | HRE | kidney: | n/a |
| 15 | chr5:179223116-179223166 | HCF | heart: | n/a |
| 16 | chr5:179225039-179225089 | U87 | brain: | n/a |
| 17 | chr5:179223454-179223504 | PANC-1 | pancreas: | n/a |
| 18 | chr5:179224984-179225034 | SK-N-SH | brain: | n/a |
| 19 | chr5:179227268-179227318 | ovcar-3 | ovarian: | n/a |
| 20 | chr5:179226753-179226803 | GM06990 | blood: | n/a |
| 21 | chr5:179225504-179225554 | HNPCEpiC | eye: | n/a |
| 22 | chr5:179225515-179225565 | HEEpiC | esophagus: | n/a |
| 23 | chr5:179225558-179225608 | H1-hESC | embryonic stem cell: | embryo |
| 24 | chr5:179226172-179226222 | IMR90 | lung: | fetal |
| 25 | chr5:179225504-179225554 | SK-N-MC | brain: | n/a |
| 26 | chr5:179225977-179226027 | HCT-116 | colon: | n/a |
| 27 | chr5:179227268-179227318 | HCF | heart: | n/a |
| 28 | chr5:179224836-179224886 | HCF | heart: | n/a |
| 29 | chr5:179226753-179226803 | AG10803 | skin: | n/a |
| 30 | chr5:179225537-179225587 | NHDF-neo | bronchial: | n/a |
| 31 | chr5:179226172-179226222 | AoSMC | blood vessel: | n/a |
| 32 | chr5:179228489-179228539 | Hela-S3 | cervix: | n/a |
| 33 | chr5:179225977-179226027 | A549 | lung: | n/a |
| 34 | chr5:179225479-179225529 | HEEpiC | esophagus: | n/a |
| 35 | chr5:179223116-179223166 | HAEpiC | amniotic membrane: | n/a |
| 36 | chr5:179225039-179225089 | PrEC | prostate: | n/a |
| 37 | chr5:179222639-179222689 | HRE | kidney: | n/a |
| 38 | chr5:179223116-179223166 | PANC-1 | pancreas: | n/a |
| 39 | chr5:179224984-179225034 | RPTEC | kidney: | n/a |
| 40 | chr5:179226009-179226059 | HCF | heart: | n/a |
| 41 | chr5:179224836-179224886 | Hepatocyte | liver: | n/a |
| 42 | chr5:179225537-179225587 | Hepatocyte | liver: | n/a |
| 43 | chr5:179224751-179224801 | NHDF-neo | bronchial: | n/a |
| 44 | chr5:179222639-179222689 | NHDF-neo | bronchial: | n/a |
| 45 | chr5:179227268-179227318 | HAEpiC | amniotic membrane: | n/a |
| 46 | chr5:179226186-179226236 | U87 | brain: | n/a |
| 47 | chr5:179226753-179226803 | SK-N-SH | brain: | n/a |
| 48 | chr5:179225515-179225565 | HRCEpiC | kidney: | n/a |
| 49 | chr5:179225558-179225608 | HCPEpiC | choroid plexus: | n/a |
| 50 | chr5:179225537-179225587 | SK-N-MC | brain: | n/a |
(count:26 , 50 per page) page:
1
| No. | Distal block | Cell Line | Cell type | Cell Stage |
|---|---|---|---|---|
| 1 | chr5:179049356..179051389-chr5:179221894..179224407,2 | MCF-7 | breast: | |
| 2 | chr5:179164536..179166178-chr5:179223167..179224801,2 | MCF-7 | breast: | |
| 3 | chr5:179157523..179162988-chr5:179219694..179224698,13 | MCF-7 | breast: | |
| 4 | chr5:179126009..179127718-chr5:179220885..179222493,2 | K562 | blood: | |
| 5 | chr22:43010882..43011449-chr5:179222925..179223848,2 | HCT-116 | colon: | |
| 6 | chr5:179104088..179107429-chr5:179222108..179224529,3 | MCF-7 | breast: | |
| 7 | chr5:179227703..179229883-chr5:179285735..179288229,2 | K562 | blood: | |
| 8 | chr5:179221198..179223904-chr5:179283563..179286738,3 | MCF-7 | breast: | |
| 9 | chr5:179204721..179205577-chr5:179222799..179223648,2 | MCF-7 | breast: | |
| 10 | chr5:179159145..179159714-chr5:179223109..179223845,2 | MCF-7 | breast: | |
| 11 | chr5:179049042..179051273-chr5:179225764..179228331,2 | MCF-7 | breast: | |
| 12 | chr5:179048548..179052839-chr5:179221765..179224480,6 | MCF-7 | breast: | |
| 13 | chr5:179125163..179127622-chr5:179228110..179231035,2 | K562 | blood: | |
| 14 | chr5:179104067..179106595-chr5:179220718..179223236,3 | MCF-7 | breast: | |
| 15 | chr5:179189767..179190816-chr5:179222590..179224521,15 | MCF-7 | breast: | |
| 16 | chr5:179049178..179050682-chr5:179227339..179229062,2 | MCF-7 | breast: | |
| 17 | chr5:179221892..179226661-chr5:179285311..179287197,6 | MCF-7 | breast: | |
| 18 | chr5:179197877..179198480-chr5:179223009..179223771,2 | MCF-7 | breast: | |
| 19 | chr5:179123572..179126776-chr5:179221240..179224069,3 | MCF-7 | breast: | |
| 20 | chr5:179227703..179229883-chr5:179285735..179289127,3 | K562 | blood: | |
| 21 | chr5:179123773..179127716-chr5:179220848..179225521,8 | MCF-7 | breast: | |
| 22 | chr5:179223013..179224914-chr5:180672992..180675408,2 | MCF-7 | breast: | |
| 23 | chr5:179158179..179161014-chr5:179220671..179223680,5 | MCF-7 | breast: | |
| 24 | chr5:179227831..179231343-chr5:179333679..179336075,3 | MCF-7 | breast: | |
| 25 | chr5:179124990..179127718-chr5:179220717..179222385,2 | K562 | blood: | |
| 26 | chr5:179159678..179161359-chr5:179228559..179231556,2 | MCF-7 | breast: |
| No data |
| miRNA name | Chromosome Location | mirBase accession |
|---|---|---|
| hsa-miR-1229-3p | chr5:179225278-179225300 | MIMAT0005584 |
| hsa-miR-1229-5p | chr5:179225323-179225346 | MIMAT0022942 |
| No data |
| Variant related genes | Relation type |
|---|---|
| LTC4S | TF binding region |
| SQSTM1 | TF binding region |
| MGAT4B | TF binding region |
| MIR1229 | TF binding region |
| LTC4S | CpG island |
| SQSTM1 | CpG island |
| MGAT4B | CpG island |
| MIR1229 | CpG island |
| ENSG00000270022 | chromatin interactions |
| ENSG00000127022 | chromatin interactions |
| ENSG00000204628 | chromatin interactions |
| ENSG00000225051 | chromatin interactions |
| ENSG00000245317 | chromatin interactions |
| ENSG00000100227 | chromatin interactions |
| ENSG00000161021 | chromatin interactions |
| ENSG00000233937 | chromatin interactions |
| ENSG00000161010 | chromatin interactions |
| ENSG00000197226 | chromatin interactions |
| ENSG00000169045 | chromatin interactions |
| HNRNPUL1 | Mature miRNA region |
| PHRF1 | Mature miRNA region |
| RPL3 | Mature miRNA region |
| IGF2BP1 | Mature miRNA region |
| DDX23 | Mature miRNA region |
| CLSTN3 | Mature miRNA region |
| INO80D | Mature miRNA region |
| FEN1 | Mature miRNA region |
| SCAMP5 | Mature miRNA region |
| SCD | Mature miRNA region |
| RUVBL2 | Mature miRNA region |
| MAPKAPK2 | Mature miRNA region |
| SORBS3 | Mature miRNA region |
| NXPE3 | Mature miRNA region |
| KDM5C | Mature miRNA region |
| CDKN1A | Mature miRNA region |
| COIL | Mature miRNA region |
| NF2 | Mature miRNA region |
| C19orf10 | Mature miRNA region |
| HNRNPD | Mature miRNA region |
| TIA1 | Mature miRNA region |
| ZNF264 | Mature miRNA region |
| PHC1 | Mature miRNA region |
| ACLY | Mature miRNA region |
| RPGRIP1L | Mature miRNA region |
| KMT2D | Mature miRNA region |
| SIK2 | Mature miRNA region |
| INTS10 | Mature miRNA region |
| AHCYL1 | Mature miRNA region |
| PHGDH | Mature miRNA region |
| HNRNPA1 | Mature miRNA region |
| PPP4C | Mature miRNA region |
| HADHB | Mature miRNA region |
| SFPQ | Mature miRNA region |
| SLC39A7 | Mature miRNA region |
| SAE1 | Mature miRNA region |
| C2orf44 | Mature miRNA region |
| CDIPT | Mature miRNA region |
| NUP210 | Mature miRNA region |
| CDC42EP4 | Mature miRNA region |
| DCAF7 | Mature miRNA region |
| LDOC1L | Mature miRNA region |
| C9orf114 | Mature miRNA region |
| POLR2D | Mature miRNA region |
| GTF2I | Mature miRNA region |
| SUPT5H | Mature miRNA region |
| CSDE1 | Mature miRNA region |
| BET1L | Mature miRNA region |
| CTCF | Mature miRNA region |
| EIF4G2 | Mature miRNA region |
| PBRM1 | Mature miRNA region |
| NEU3 | Mature miRNA region |
| GPI | Mature miRNA region |
| NME2 | Mature miRNA region |
| CPT1B | Mature miRNA region |
| FMNL2 | Mature miRNA region |
| PPP6R1 | Mature miRNA region |
| TSC22D3 | Mature miRNA region |
| ARL6IP1 | Mature miRNA region |
| LRIT1 | Mature miRNA region |
| SRCAP | Mature miRNA region |
| CRISP3 | Mature miRNA region |
| NAA50 | Mature miRNA region |
| CTNND1 | Mature miRNA region |
| DCTD | Mature miRNA region |
| MAD2L2 | Mature miRNA region |
| OTUD7B | Mature miRNA region |
| TUBG1 | Mature miRNA region |
| OPA3 | Mature miRNA region |
| NAPEPLD | Mature miRNA region |
| ALS2 | Mature miRNA region |
| CEP350 | Mature miRNA region |
| EEF2 | Mature miRNA region |
| CHCHD2 | Mature miRNA region |
| RNF40 | Mature miRNA region |
| KCTD15 | Mature miRNA region |
| KRT28 | Mature miRNA region |
| HNRNPA3 | Mature miRNA region |
| ATP5A1 | Mature miRNA region |
| DAG1 | Mature miRNA region |
| TARDBP | Mature miRNA region |
| KIF24 | Mature miRNA region |
| AP2M1 | Mature miRNA region |
| BAP1 | Mature miRNA region |
| EML1 | Mature miRNA region |
| ZMYM2 | Mature miRNA region |
| ZDHHC7 | Mature miRNA region |
| PRDX4 | Mature miRNA region |
| EPB41L2 | Mature miRNA region |
| PSMC5 | Mature miRNA region |
| CTNNBL1 | Mature miRNA region |
| TRRAP | Mature miRNA region |
| FOXK1 | Mature miRNA region |
| BRD2 | Mature miRNA region |
| REXO2 | Mature miRNA region |
| ACOT7 | Mature miRNA region |
| MPP2 | Mature miRNA region |
| ABCC5 | Mature miRNA region |
| SRP72 | Mature miRNA region |
| CEP152 | Mature miRNA region |
| MDK | Mature miRNA region |
| AIF1L | Mature miRNA region |
| MED19 | Mature miRNA region |
| CPNE1 | Mature miRNA region |
| TUSC3 | Mature miRNA region |
| PAK4 | Mature miRNA region |
| ITGA5 | Mature miRNA region |
| LRBA | Mature miRNA region |
| YWHAZ | Mature miRNA region |
| CTDNEP1 | Mature miRNA region |
| FOXP1 | Mature miRNA region |
| HIST4H4 | Mature miRNA region |
| SNX12 | Mature miRNA region |
| PITPNB | Mature miRNA region |
| GAPDH | Mature miRNA region |
| HYPK | Mature miRNA region |
| PRKRIP1 | Mature miRNA region |
| RPS15 | Mature miRNA region |
| KPNB1 | Mature miRNA region |
| CEP55 | Mature miRNA region |
| ERC1 | Mature miRNA region |
| PHF8 | Mature miRNA region |
| ADPRHL2 | Mature miRNA region |
| SLC16A13 | Mature miRNA region |
| HIST1H3G | Mature miRNA region |
| TNRC6B | Mature miRNA region |
| TUBA1B | Mature miRNA region |
| SAFB | Mature miRNA region |
| PTBP3 | Mature miRNA region |
| VWA8 | Mature miRNA region |
| RPL7A | Mature miRNA region |
| PTPRF | Mature miRNA region |
| ZNF687 | Mature miRNA region |
| STAT5B | Mature miRNA region |
| No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
|---|---|---|---|---|---|---|---|
| 1 | rs272431 | chr5:179221789-179221790 | Enhancers Weak transcription Flanking Active TSS Flanking Bivalent TSS/Enh Genic enhancers Active TSS Bivalent Enhancer | TF binding regionChromatin interactive region | 7 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
| 2 | rs568748049 | chr5:179221797-179221798 | Enhancers Weak transcription Flanking Active TSS Flanking Bivalent TSS/Enh Genic enhancers Active TSS Bivalent Enhancer | TF binding regionChromatin interactive region | 7 gene(s) | Overlapped CNVs | n/a |
| 3 | rs536199646 | chr5:179221799-179221800 | Enhancers Weak transcription Flanking Active TSS Flanking Bivalent TSS/Enh Genic enhancers Active TSS Bivalent Enhancer | TF binding regionChromatin interactive region | 7 gene(s) | Overlapped CNVs | n/a |
| 4 | rs190736573 | chr5:179221804-179221805 | Enhancers Weak transcription Active TSS Bivalent Enhancer Flanking Active TSS Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3' Genic enhancers | TF binding regionChromatin interactive region | 7 gene(s) | Overlapped CNVs | n/a |
| 5 | rs566102079 | chr5:179221805-179221806 | Enhancers Weak transcription Active TSS Bivalent Enhancer Flanking Active TSS Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3' Genic enhancers | TF binding regionChromatin interactive region | 7 gene(s) | Overlapped CNVs | n/a |
| 6 | rs540027891 | chr5:179221807-179221808 | Enhancers Weak transcription Active TSS Bivalent Enhancer Flanking Active TSS Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3' Genic enhancers | TF binding regionChromatin interactive region | 7 gene(s) | Overlapped CNVs | n/a |
| 7 | rs557943535 | chr5:179221817-179221818 | Enhancers Weak transcription Active TSS Bivalent Enhancer Flanking Active TSS Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3' Genic enhancers | TF binding regionChromatin interactive region | 7 gene(s) | Overlapped CNVs | n/a |
| 8 | rs569830545 | chr5:179221838-179221839 | Enhancers Weak transcription Active TSS Bivalent Enhancer Flanking Active TSS Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3' Genic enhancers | TF binding regionChromatin interactive region | 7 gene(s) | Overlapped CNVs | n/a |
| 9 | rs368977593 | chr5:179221885-179221886 | Enhancers Weak transcription Active TSS Bivalent Enhancer Flanking Active TSS Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3' Genic enhancers | TF binding regionChromatin interactive region | 7 gene(s) | Overlapped CNVs | n/a |
| 10 | rs571020323 | chr5:179221886-179221887 | Enhancers Weak transcription Active TSS Bivalent Enhancer Flanking Active TSS Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3' Genic enhancers | TF binding regionChromatin interactive region | 7 gene(s) | Overlapped CNVs | n/a |
| 11 | rs549602705 | chr5:179221981-179221982 | Enhancers Weak transcription Active TSS Bivalent Enhancer Flanking Active TSS Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3' Genic enhancers | TF binding regionChromatin interactive region | 7 gene(s) | Overlapped CNVs | n/a |
| 12 | rs58826518 | chr5:179222041-179222042 | Flanking Active TSS Weak transcription Enhancers Bivalent Enhancer Active TSS Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3' Genic enhancers | TF binding regionChromatin interactive region | 7 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
| 13 | rs182123489 | chr5:179222044-179222045 | Flanking Active TSS Weak transcription Enhancers Bivalent Enhancer Active TSS Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3' Genic enhancers | TF binding regionChromatin interactive region | 7 gene(s) | Overlapped CNVs | n/a |
| 14 | rs541009518 | chr5:179222070-179222071 | Flanking Active TSS Weak transcription Enhancers Bivalent Enhancer Active TSS Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3' Genic enhancers | TF binding regionChromatin interactive region | 7 gene(s) | Overlapped CNVs | n/a |
| 15 | rs116280439 | chr5:179222128-179222129 | Flanking Active TSS Weak transcription Enhancers Bivalent Enhancer Active TSS Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3' Genic enhancers | TF binding regionChromatin interactive region | 7 gene(s) | Overlapped CNVs | n/a |
| 16 | rs577733234 | chr5:179222143-179222144 | Flanking Active TSS Weak transcription Enhancers Bivalent Enhancer Active TSS Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3' Genic enhancers | TF binding regionChromatin interactive region | 7 gene(s) | Overlapped CNVs | n/a |
| 17 | rs545201267 | chr5:179222177-179222178 | Flanking Active TSS Weak transcription Enhancers Bivalent Enhancer Active TSS Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3' Genic enhancers | TF binding regionChromatin interactive region | 7 gene(s) | Overlapped CNVs | n/a |
| 18 | rs186263070 | chr5:179222195-179222196 | Flanking Active TSS Weak transcription Enhancers Bivalent Enhancer Active TSS Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3' Genic enhancers | TF binding regionChromatin interactive region | 7 gene(s) | Overlapped CNVs | n/a |
| 19 | rs530649684 | chr5:179222216-179222217 | Flanking Active TSS Active TSS Enhancers Weak transcription Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3' Bivalent Enhancer Bivalent/Poised TSS | TF binding regionChromatin interactive region | 7 gene(s) | Overlapped CNVs | n/a |
| 20 | rs535344572 | chr5:179222297-179222298 | Flanking Active TSS Active TSS Enhancers Weak transcription Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3' Bivalent Enhancer Bivalent/Poised TSS | TF binding regionChromatin interactive region | 7 gene(s) | Overlapped CNVs | n/a |
| 21 | rs560905665 | chr5:179222329-179222330 | Flanking Active TSS Active TSS Enhancers Weak transcription Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3' Bivalent Enhancer Bivalent/Poised TSS | TF binding regionChromatin interactive region | 7 gene(s) | Overlapped CNVs | n/a |
| 22 | rs528098272 | chr5:179222350-179222351 | Flanking Active TSS Active TSS Enhancers Weak transcription Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3' Bivalent Enhancer Bivalent/Poised TSS | TF binding regionChromatin interactive region | 7 gene(s) | Overlapped CNVs | n/a |
| 23 | rs558203852 | chr5:179222353-179222354 | Flanking Active TSS Active TSS Enhancers Weak transcription Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3' Bivalent Enhancer Bivalent/Poised TSS | TF binding regionChromatin interactive region | 7 gene(s) | Overlapped CNVs | n/a |
| 24 | rs370009631 | chr5:179222369-179222370 | Flanking Active TSS Active TSS Enhancers Weak transcription Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3' Bivalent Enhancer Bivalent/Poised TSS | TF binding regionChromatin interactive region | 7 gene(s) | Overlapped CNVs | n/a |
| 25 | rs41458244 | chr5:179222377-179222378 | Flanking Active TSS Active TSS Enhancers Weak transcription Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3' Bivalent Enhancer Bivalent/Poised TSS | TF binding regionChromatin interactive region | 7 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
| 26 | rs566385747 | chr5:179222445-179222446 | Active TSS Flanking Active TSS Enhancers Weak transcription Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3' Bivalent/Poised TSS | TF binding regionChromatin interactive region | 7 gene(s) | Overlapped CNVs | n/a |
| 27 | rs533330702 | chr5:179222474-179222475 | Active TSS Flanking Active TSS Enhancers Weak transcription Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3' Bivalent/Poised TSS | TF binding regionChromatin interactive region | 7 gene(s) | Overlapped CNVs | n/a |
| 28 | rs551985667 | chr5:179222482-179222483 | Active TSS Flanking Active TSS Enhancers Weak transcription Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3' Bivalent/Poised TSS | TF binding regionChromatin interactive region | 7 gene(s) | Overlapped CNVs | n/a |
| 29 | rs569795765 | chr5:179222489-179222490 | Active TSS Flanking Active TSS Enhancers Weak transcription Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3' Bivalent/Poised TSS | TF binding regionChromatin interactive region | 7 gene(s) | Overlapped CNVs | n/a |
| 30 | rs370246522 | chr5:179222493-179222494 | Active TSS Flanking Active TSS Enhancers Weak transcription Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3' Bivalent/Poised TSS | TF binding regionChromatin interactive region | 7 gene(s) | Overlapped CNVs | n/a |
| 31 | rs540038559 | chr5:179222503-179222504 | Active TSS Flanking Active TSS Enhancers Weak transcription Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3' Bivalent/Poised TSS | TF binding regionChromatin interactive region | 7 gene(s) | Overlapped CNVs | n/a |
| 32 | rs537198261 | chr5:179222515-179222516 | Active TSS Flanking Active TSS Enhancers Weak transcription Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3' Bivalent/Poised TSS | TF binding regionChromatin interactive region | 7 gene(s) | Overlapped CNVs | n/a |
| 33 | rs555333988 | chr5:179222530-179222531 | Active TSS Flanking Active TSS Enhancers Weak transcription Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3' Bivalent/Poised TSS | TF binding regionChromatin interactive region | 7 gene(s) | Overlapped CNVs | n/a |
| 34 | rs34011389 | chr5:179222544-179222545 | Active TSS Flanking Active TSS Enhancers Weak transcription Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3' Bivalent/Poised TSS | TF binding regionChromatin interactive region | 7 gene(s) | Overlapped CNVs | n/a |
| 35 | rs567283587 | chr5:179222561-179222562 | Active TSS Flanking Active TSS Enhancers Weak transcription Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3' Bivalent/Poised TSS | Chromatin interactive region | 6 gene(s) | Overlapped CNVs | n/a |
| 36 | rs535037049 | chr5:179222573-179222574 | Active TSS Flanking Active TSS Enhancers Weak transcription Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3' Bivalent/Poised TSS | Chromatin interactive region | 6 gene(s) | Overlapped CNVs | n/a |
| 37 | rs145738814 | chr5:179222575-179222576 | Active TSS Flanking Active TSS Enhancers Weak transcription Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3' Bivalent/Poised TSS | Chromatin interactive region | 6 gene(s) | Overlapped CNVs | n/a |
| 38 | rs577901357 | chr5:179222599-179222600 | Active TSS Flanking Active TSS Enhancers Weak transcription Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3' Bivalent/Poised TSS | Chromatin interactive region | 6 gene(s) | Overlapped CNVs | n/a |
| 39 | rs201270274 | chr5:179222602-179222603 | Active TSS Flanking Active TSS Weak transcription Flanking Bivalent TSS/Enh Enhancers Transcr. at gene 5' and 3' Bivalent/Poised TSS Bivalent Enhancer | Chromatin interactive region | 6 gene(s) | Overlapped CNVs | n/a |
| 40 | rs557239059 | chr5:179222606-179222607 | Active TSS Flanking Active TSS Weak transcription Flanking Bivalent TSS/Enh Enhancers Transcr. at gene 5' and 3' Bivalent/Poised TSS Bivalent Enhancer | Chromatin interactive region | 6 gene(s) | Overlapped CNVs | n/a |
| 41 | rs368527006 | chr5:179222609-179222610 | Active TSS Flanking Active TSS Weak transcription Flanking Bivalent TSS/Enh Enhancers Transcr. at gene 5' and 3' Bivalent/Poised TSS Bivalent Enhancer | Chromatin interactive region | 6 gene(s) | Overlapped CNVs | n/a |
| 42 | rs575400315 | chr5:179222627-179222628 | Active TSS Flanking Active TSS Weak transcription Flanking Bivalent TSS/Enh Enhancers Transcr. at gene 5' and 3' Bivalent/Poised TSS Bivalent Enhancer | Chromatin interactive region | 6 gene(s) | Overlapped CNVs | n/a |
| 43 | rs372785497 | chr5:179222650-179222651 | Active TSS Flanking Active TSS Weak transcription Flanking Bivalent TSS/Enh Enhancers Transcr. at gene 5' and 3' Bivalent/Poised TSS Bivalent Enhancer | Chromatin interactive region | 6 gene(s) | Overlapped CNVs | n/a |
| 44 | rs542702448 | chr5:179222652-179222653 | Active TSS Flanking Active TSS Weak transcription Flanking Bivalent TSS/Enh Enhancers Transcr. at gene 5' and 3' Bivalent/Poised TSS Bivalent Enhancer | Chromatin interactive region | 6 gene(s) | Overlapped CNVs | n/a |
| 45 | rs376663667 | chr5:179222658-179222659 | Active TSS Flanking Active TSS Weak transcription Flanking Bivalent TSS/Enh Enhancers Transcr. at gene 5' and 3' Bivalent/Poised TSS Bivalent Enhancer | Chromatin interactive region | 6 gene(s) | Overlapped CNVs | n/a |
| 46 | rs368740449 | chr5:179222670-179222671 | Active TSS Flanking Active TSS Weak transcription Flanking Bivalent TSS/Enh Enhancers Transcr. at gene 5' and 3' Bivalent/Poised TSS Bivalent Enhancer | Chromatin interactive region | 6 gene(s) | Overlapped CNVs | n/a |
| 47 | rs376751526 | chr5:179222688-179222689 | Active TSS Flanking Active TSS Weak transcription Flanking Bivalent TSS/Enh Enhancers Transcr. at gene 5' and 3' Bivalent/Poised TSS Bivalent Enhancer | Chromatin interactive region | 6 gene(s) | Overlapped CNVs | n/a |
| 48 | rs540238590 | chr5:179222736-179222737 | Active TSS Flanking Active TSS Weak transcription Flanking Bivalent TSS/Enh Enhancers Transcr. at gene 5' and 3' Bivalent/Poised TSS Bivalent Enhancer | Chromatin interactive region | 6 gene(s) | Overlapped CNVs | n/a |
| 49 | rs369800948 | chr5:179222833-179222834 | Active TSS Bivalent/Poised TSS Flanking Active TSS Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3' Weak transcription Enhancers | Chromatin interactive region | 6 gene(s) | Overlapped CNVs | n/a |
| 50 | rs150331511 | chr5:179222841-179222842 | Active TSS Bivalent/Poised TSS Flanking Active TSS Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3' Weak transcription Enhancers | Chromatin interactive region | 6 gene(s) | Overlapped CNVs | n/a |
| Disease | PMID | Source |
|---|---|---|
| Ewing''s sarcoma | 21437220 | CNVD |
| Glioblastoma multiforme | 21080181 | CNVD |
| Acute lymphoblastic leukemia | 17690704 | CNVD |
| Gastrointestinal stromal cancer | 16982739 | CNVD |
| Medulloblastoma | 21979893 | CNVD |
| Phyllodes tumor | 17334353 | CNVD |
| Malaria | 21533027 | CNVD |
| Renal cell carcinoma | 19461508 | CNVD |
| Cancer | 20164919 | CNVD |
| T-cell prolymphocytic leukemia | 19278963 | CNVD |
| Acute lymphoblastic leukemia | 20435627 | CNVD |
| Cancer | 16751803 | CNVD |
| Acute lymphoblastic leukemia | 20067559 | CNVD |
| Glioma | 20126413 | CNVD |
| Cancer | 22429812 | CNVD |
| Cancer | 21637783 | CNVD |
| Colorectal cancer | 20709793 | CNVD |
| Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
| Liposarcoma | 21253554 | CNVD |
| Acute lymphoblastic leukemia | 21390130 | CNVD |
| Endometrial cancer | 22040021 | CNVD |
| Breast cancer | 21264507 | CNVD |
| Esophageal squamous carcinoma | 21637470 | CNVD |
| Glioblastoma multiforme | 19960244 | CNVD |
| Glioblastoma multiforme | 17387387 | CNVD |
| Leukemia | 17361228 | CNVD |
| Myelodysplastic syndrome | 18508791 | CNVD |
| 5q-syndrome | 17576883 | CNVD |
| Gastric cancer | 17908304 | CNVD |
| Lung cancer | 16740712 | CNVD |
| Oral squamous cell carcinoma | 17134496 | CNVD |
| Urothelial carcinoma | 21177765 | CNVD |
| Esophageal adenocarcinoma | 19417022 | CNVD |
| Barrett''s syndrome | 19417022 | CNVD |
| Thyroid cancer | 19087340 | CNVD |
| Acute myeloid leukemia | 20729466 | CNVD |
| lymphocytic leukemia | 21291569 | CNVD |
| Multiple myeloma | 17550852 | CNVD |
| Salivary gland tumor | 18059337 | CNVD |
| Renal cell carcinoma | 19377443 | CNVD |
| Lung cancer | 18438408 | CNVD |
| Gastrointestinal stromal cancer | 19259404 | CNVD |
| Renal cell carcinoma | 18592004 | CNVD |
| Hodgkin''s lymphoma | 17606441 | CNVD |
| Breast cancer | 20668451 | CNVD |
| Cancer | 20668451 | CNVD |
| Lung cancer | 20668451 | CNVD |
| Ovarian cancer | 20668451 | CNVD |
| Pancreas cancer | 20668451 | CNVD |
| Prostate cancer | 20668451 | CNVD |
| Myofibroblastic sarcoma | 19369631 | CNVD |
| Embryonal rhabdomyosarcoma | 16790082 | CNVD |
| Biliary cancer | 20360734 | CNVD |
| Breast cancer | 20360734 | CNVD |
| Coronary artery disease | 20360734 | CNVD |
| Crohn''s disease | 20360734 | CNVD |
| Hypertension | 20360734 | CNVD |
| Rheumatoid arthritis | 20360734 | CNVD |
| Type 1 diabetes | 20360734 | CNVD |
| Type 2 diabetes | 20360734 | CNVD |
| Prostate cancer | 18632612 | CNVD |
| epilepsy | 18472482 | CNVD |
| Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
| Sotos syndrome | 21572526 | CNVD |
| T-cell acute lymphoblastic leukemia | 20065082 | CNVD |
| Sotos syndrome | 17561922 | CNVD |
| Sotos syndrome | 16773131 | CNVD |
| Mental retardation | 16773131 | CNVD |
| Sotos syndrome | 22470819 | CNVD |
| Non-syndromic sensorineural hearing loss | 20606397 | CNVD |
| Acute myeloid leukemia | 18000384 | CNVD |
| Sudden cardiac death | 19188705 | CNVD |
| Basal cell lymphoma | 16317097 | CNVD |
| Chordoma | 18071362 | CNVD |
| Diffuse large b-cell lymphoma | 16317097 | CNVD |
| Olfactory neuroblastoma | 18408657 | CNVD |
| Chronic lymphocytic leukemia | 21546498 | CNVD |
| abnormal development | 18461090 | CNVD |
| T-cell acute lymphoblastic leukemia | 18185524 | CNVD |
| Lung cancer | 17297452 | CNVD |
| Cancer | 20164920 | CNVD |
| Breast cancer | 21509527 | CNVD |
| Breast cancer | 21804112 | CNVD |
| Myelofibrosis | 22110671 | CNVD |
| Sotos syndrome | 22283845 | CNVD |
| Breast cancer | 16272173 | CNVD |
| Sotos syndrome | 20503325 | CNVD |
| Lung adenocarcinoma | 17086460 | CNVD |
| Congenital Hypertrichosis Syndrome | 21636067 | CNVD |
| T-cell acute lymphoblastic leukemia | 19406988 | CNVD |
| Breast cancer | 19181860 | CNVD |
| Acute lymphoblastic leukemia | 21098271 | CNVD |
| Ehlers-danlos syndrome | 17576883 | CNVD |
| Lung cancer | 17086460 | CNVD |
| Autism | 19246517 | CNVD |
| Basal cell lymphoma | 19029149 | CNVD |
| Diffuse large b-cell lymphoma | 19029149 | CNVD |
| Autism | 20808228 | CNVD |
| small cell lung cancer | 20016488 | CNVD |
| Breast cancer | 22522925 | CNVD |
| No. | Chromosome Location | Chromatin state | Cell line | Tissue |
|---|---|---|---|---|
| 1 | chr5:179202000-179221800 | Weak transcription | iPS-15b Cell Line | embryonic stem cell |
| 2 | chr5:179203600-179222000 | Weak transcription | H9 Cell Line | embryonic stem cell |
| 3 | chr5:179205200-179221800 | Weak transcription | Placenta Amnion | Placenta Amnion |
| 4 | chr5:179207600-179222200 | Weak transcription | Ganglion Eminence derived primary cultured neurospheres | brain |
| 5 | chr5:179207600-179222600 | Weak transcription | Aorta | Aorta |
| 6 | chr5:179207800-179222200 | Weak transcription | Foreskin Melanocyte Primary Cells skin03 | Skin |
| 7 | chr5:179209400-179222200 | Weak transcription | H9 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
| 8 | chr5:179215600-179223200 | Weak transcription | HSMMtube | muscle |
| 9 | chr5:179218600-179222800 | Enhancers | Primary monocytes fromperipheralblood | blood |
| 10 | chr5:179218800-179222000 | Enhancers | Liver | Liver |
| 11 | chr5:179219200-179221800 | Enhancers | HepG2 | liver |
| 12 | chr5:179219400-179222200 | Enhancers | ES-UCSF4 Cell Line | embryonic stem cell |
| 13 | chr5:179219400-179222400 | Enhancers | Primary neutrophils fromperipheralblood | blood |
| 14 | chr5:179219400-179222400 | Enhancers | Primary B cells from cord blood | blood |
| 15 | chr5:179219600-179222400 | Enhancers | H1 Derived Mesenchymal Stem Cells | ES cell derived |
| 16 | chr5:179219600-179222400 | Enhancers | Primary T helper memory cells from peripheral blood 1 | blood |
| 17 | chr5:179219600-179222800 | Weak transcription | H9 Derived Neuron Cultured Cells | ES cell derived |
| 18 | chr5:179219800-179221800 | Flanking Active TSS | Monocytes-CD14+_RO01746 | blood |
| 19 | chr5:179219800-179222200 | Weak transcription | Fetal Brain Female | brain |
| 20 | chr5:179220000-179221800 | Enhancers | Rectal Mucosa Donor 31 | rectum |
| 21 | chr5:179220000-179222200 | Enhancers | Fetal Lung | lung |
| 22 | chr5:179220000-179223000 | Flanking Active TSS | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
| 23 | chr5:179220200-179222000 | Enhancers | Primary T killer memory cells from peripheral blood | blood |
| 24 | chr5:179220200-179222000 | Enhancers | GM12878-XiMat | blood |
| 25 | chr5:179220200-179222200 | Enhancers | H1 Cell Line | embryonic stem cell |
| 26 | chr5:179220200-179222200 | Weak transcription | Brain Germinal Matrix | brain |
| 27 | chr5:179220200-179222200 | Enhancers | Pancreas | Pancrea |
| 28 | chr5:179220200-179222200 | Enhancers | Stomach Mucosa | stomach |
| 29 | chr5:179220200-179222400 | Enhancers | Primary T cells from cord blood | blood |
| 30 | chr5:179220200-179222400 | Enhancers | Primary T killer naive cells fromperipheralblood | blood |
| 31 | chr5:179220200-179223800 | Flanking Active TSS | Primary hematopoietic stem cells short term culture | blood |
| 32 | chr5:179220400-179221800 | Enhancers | Esophagus | oesophagus |
| 33 | chr5:179220400-179222000 | Enhancers | ES-I3 Cell Line | embryonic stem cell |
| 34 | chr5:179220400-179222000 | Enhancers | iPS DF 19.11 Cell Line | embryonic stem cell |
| 35 | chr5:179220400-179222200 | Enhancers | Primary T helper cells PMA-I stimulated | -- |
| 36 | chr5:179220400-179222200 | Enhancers | Fetal Adrenal Gland | Adrenal Gland |
| 37 | chr5:179220400-179222600 | Enhancers | Muscle Satellite Cultured Cells | -- |
| 38 | chr5:179220400-179222600 | Enhancers | Sigmoid Colon | Sigmoid Colon |
| 39 | chr5:179220600-179221800 | Weak transcription | iPS-18 Cell Line | embryonic stem cell |
| 40 | chr5:179220600-179221800 | Enhancers | Primary T regulatory cells fromperipheralblood | blood |
| 41 | chr5:179220600-179221800 | Flanking Active TSS | Left Ventricle | heart |
| 42 | chr5:179220600-179222000 | Enhancers | Primary T helper cells fromperipheralblood | blood |
| 43 | chr5:179220600-179222000 | Enhancers | HMEC | breast |
| 44 | chr5:179220600-179222000 | Enhancers | NHEK | skin |
| 45 | chr5:179220600-179222200 | Enhancers | Primary T helper naive cells from peripheral blood | blood |
| 46 | chr5:179220600-179222400 | Enhancers | Primary B cells from peripheral blood | blood |
| 47 | chr5:179220600-179222400 | Enhancers | Primary mononuclear cells fromperipheralblood | Blood |
| 48 | chr5:179220600-179222400 | Enhancers | NHLF | lung |
| 49 | chr5:179220600-179223000 | Flanking Active TSS | Adipose Nuclei | Adipose |
| 50 | chr5:179220600-179223000 | Flanking Active TSS | Stomach Smooth Muscle | stomach |






